Z79.81

Non-billable

Long term (current) use of agents affecting estrogen receptors and estrogen levels

Z79.81 is the ICD-10-CM code for Long term (current) use of agents affecting estrogen receptors and estrogen levels. It is a non-billable category code — use a more specific child code such as Z79.810 for billing.

Status
Header (non-billable)
Chapter
Z00-Z99
Parent
Z79.8
Subcodes
3
Edition
FY2026

Z00-Z99 Factors influencing health status and contact with health services

Excludes1 — not coded here

  • hormone replacement therapy (Z79.890)

Code first

  • , if applicable:
  • malignant neoplasm of breast (C50.-)
  • malignant neoplasm of prostate (C61)

Use additional code

  • code, if applicable, to identify:
  • estrogen receptor positive status (Z17.0)
  • family history of breast cancer (Z80.3)
  • genetic susceptibility to malignant neoplasm (cancer) (Z15.0-)
  • personal history of breast cancer (Z85.3)
  • personal history of prostate cancer (Z85.46)
  • postmenopausal status (Z78.0)

Frequently asked questions

What is ICD-10 code Z79.81?
Z79.81 is the ICD-10-CM code for "Long term (current) use of agents affecting estrogen receptors and estrogen levels". It falls under Z00-Z99 Factors influencing health status and contact with health services.
Is Z79.81 a billable code?
No — Z79.81 is a non-billable header code. Use a more specific child code (such as Z79.810) for billing.
What are the subcodes of Z79.81?
Z79.81 has 3 more specific child codes, including Z79.810, Z79.811, Z79.818.
What is excluded from Z79.81?
Excludes1 (not coded here): hormone replacement therapy (Z79.890).

Source: CMS ICD-10-CM FY2026. For informational purposes only — not medical advice. See our medical disclaimer.

Look up another ICD-10 code or condition

Powered by Eleplan

Free ICD-10 lookup is just the start. Eleplan keeps the whole care plan in one place.

Diagnoses, medications, documents, appointments, and the whole care team — organized and always in sync, with Ellie, your AI care assistant, on top of it. Free to start.